Effect of latamoxef sodium for treating patients with pelvic inflammatory disease on their lower abdominal pain and quality of life
Objective:To analyze the effect of latamoxef sodium for treating patients with pelvic inflammatory disease on their lower abdominal pain and quality of life.Methods:A total of 104 patients with pelvic inflammatory disease who were diagnosed in the hospital were selected as the study subjects and were divided into two groups(52 cases in each group)according to the different treatment methods from January 2022 to December 2023.The patients in the control group were given the treatment of metronidazole and the patients in the observation group were given the treat-ment of latamoxef sodium.Visual analogue scale(VAS),self-rating depression scale(SDS),self-rating anxiety scale(SAS)and Chinese version of brief health questionnaire(SF-36)were used to assess the situations of the lower abdom-inal pain and the improvement of the quality of life of the patients in the two groups.Results:After 10 days of the treatment,the clinical effective rate(92.3％)of the patients in the observation group was significantly higher than that(76.9％)of the patients in the control group.The VAS score of the patients in the two groups after treatment had de-creased significantly,and which(0.63±0.66 points)of the patients in the observation group was significantly lower than that(1.35±0.84 points)of the patients in the control group.The scores of SDS(36.63±4.68 points)and SAS(35.54±4.08 points)of the patients in the observation group were significantly lower than those(41.65±5.22 points and 39.77±4.47 points)of the patients in the control group.The scores of physical component summary(PCS)and mental component summary(MCS)in SF-36 of the patients in the two groups after treatment had decreased signifi-cantly,and which(77.37±4.64 points and 80.12±3.53 points)of the patients in the observation group were signifi-cantly higher than those(73.40±4.86 points and 74.56±3.44 points)of the patients in the control group(all P＜0.05).Conclusion:Latamoxef sodium has definite effectiveness in the treatment of the patients with pelvic inflammatory disease,and which can effectively reduce the degree of the lower abdominal pain and improve the quality of life of the patients.
Pelvic inflammatory diseaseLatamoxef sodiumLower abdominal painQuality of lifeEffectiveness of treatment
万方数据
维普
